Lord Abbett Health Care R6 (LHCVX)

Fund Assets	8.74M
Expense Ratio	0.68%
Min. Investment	$0.00
Turnover	91.00%
Dividend (ttm)	0.08
Dividend Yield	0.35%
Dividend Growth	-23.52%
Payout Frequency	Annual
Ex-Dividend Date	Dec 2, 2025

Previous Close	24.16
YTD Return	5.69%
1-Year Return	15.58%
5-Year Return	25.16%
52-Week Low	20.79
52-Week High	25.45
Beta (5Y)	n/a
Holdings	55
Inception Date	Jul 31, 2019

About LHCVX

Lord Abbett Health Care Fund Class R6 is a mutual fund that primarily invests in the stocks of companies within the healthcare sector. Its central objective is to provide long-term capital growth by targeting firms engaged in healthcare services, pharmaceuticals, biotechnology, medical devices, and related industries. The fund leverages the expertise of its management team to construct a diversified portfolio with exposure to various healthcare sub-sectors, aiming to benefit from demographic trends, innovation in medical technology, and shifting healthcare regulations. This fund is designed to offer investors targeted access to a sector that plays a critical role in the global economy, impacting everything from patient care and medical research to drug development and healthcare infrastructure. By focusing exclusively on the healthcare industry, the fund serves investors seeking sector-specific diversification within their broader investment portfolios, and it is often used as a tool for capitalizing on both defensive and growth opportunities inherent to the healthcare market.

• Fund Family: Lord Abbett
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: Nasdaq
• Ticker Symbol: LHCVX
• Share Class: Class R6
• Index: MSCI ACWI/Health Care NR Index

Performance

LHCVX had a total return of 15.58% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.95%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
LHCOX	Class F3	0.68%
LHCIX	Class I	0.78%
LHCFX	Class F	0.78%
LHCTX	Class R5	0.78%

Top 10 Holdings

44.28% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.72%
UnitedHealth Group Incorporated	UNH	5.57%
Johnson & Johnson	JNJ	5.11%
Novartis AG	NOVN	4.32%
Natera, Inc.	NTRA	3.71%
Gilead Sciences, Inc.	GILD	3.64%
CVS Health Corporation	CVS	3.44%
Guardant Health, Inc.	GH	2.69%
Galderma Group AG	GALD	2.68%
Thermo Fisher Scientific Inc.	TMO	2.39%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 2, 2025	$0.0839	Dec 2, 2025
Nov 26, 2024	$0.1097	Nov 26, 2024
Nov 22, 2022	$0.0471	Nov 22, 2022
Nov 23, 2021	$1.4724	Nov 23, 2021
Nov 24, 2020	$2.3345	Nov 24, 2020
Nov 21, 2019	$0.0104	Nov 21, 2019

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Oct 17, 2026

Data Sources Report a data error